This course will review the role and significance of hs-CRP as a biomarker in measuring inflammation and CVD risk and as a screening tool for testing cardiovascular health.Important Dates: Date of Release: November 4, 2026Term of Approval/Date of Expiration: November 4, 2027 Learner Objectives: Upon completion of this activity, you should be able to:
Describe the role of hs-CRP as a biomarker in measuring inflammation and CVD risk.
Define key terminology related to hs-CRP, inflammation, and CVD risk.
Explain the significance of hs-CRP screening and testing in cardiovascular health.
Acknowledgement Educational grant support provided by: Novo Nordisk.Faculty:Brittany Weber, MD, FACCPayal Kohli, MD, FACCPaul M. Ridker, MD, MPH, FACC